AMP Capital Investors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-25,424
| Closed | -$4.8M | – | 230 |
|
|
2021
Q3 | $4.8M | Sell |
25,424
-3,684
| -13% | -$695K | 0.03% | 557 |
|
|
2021
Q2 | $4.92M | Hold |
29,108
| – | – | 0.02% | 607 |
|
|
2021
Q1 | $4.09M | Sell |
29,108
-259
| -0.9% | -$36.4K | 0.02% | 650 |
|
|
2020
Q4 | $3.85M | Sell |
29,367
-2,166
| -7% | -$284K | 0.02% | 645 |
|
|
2020
Q3 | $4.57M | Buy |
31,533
+136
| +0.4% | +$19.7K | 0.03% | 553 |
|
|
2020
Q2 | $4.64M | Sell |
31,397
-155
| -0.5% | -$22.9K | 0.03% | 524 |
|
|
2020
Q1 | $3.43M | Hold |
31,552
| – | – | 0.03% | 558 |
|
|
2019
Q4 | $3.62M | Buy |
31,552
+5,495
| +21% | +$630K | 0.02% | 644 |
|
|
2019
Q3 | $2.11M | Sell |
26,057
-376
| -1% | -$30.5K | 0.01% | 741 |
|
|
2019
Q2 | $1.88M | Hold |
26,433
| – | – | 0.01% | 767 |
|
|
2019
Q1 | $2.39M | Sell |
26,433
-1,193
| -4% | -$108K | 0.01% | 715 |
|
|
2018
Q4 | $1.94M | Sell |
27,626
-102
| -0.4% | -$7.18K | 0.01% | 728 |
|
|
2018
Q3 | $2.5M | Sell |
27,728
-8,700
| -24% | -$784K | 0.01% | 711 |
|
|
2018
Q2 | $3.59M | Sell |
36,428
-2,300
| -6% | -$227K | 0.02% | 619 |
|
|
2018
Q1 | $5.03M | Buy |
38,728
+11,693
| +43% | +$1.52M | 0.03% | 534 |
|
|
2017
Q4 | $3.43M | Buy |
+27,035
| New | +$3.43M | 0.02% | 645 |
|
|
2016
Q4 | – | Sell |
-19,559
| Closed | -$1.37M | – | 1209 |
|
|
2016
Q3 | $1.37M | Hold |
19,559
| – | – | 0.01% | 805 |
|
|
2016
Q2 | $1.09M | Hold |
19,559
| – | – | 0.01% | 827 |
|
|
2016
Q1 | $1.16M | Sell |
19,559
-100
| -0.5% | -$5.91K | 0.01% | 809 |
|
|
2015
Q4 | $1.86M | Sell |
19,659
-9,353
| -32% | -$884K | 0.01% | 733 |
|
|
2015
Q3 | $2.24M | Buy |
29,012
+9,953
| +52% | +$770K | 0.02% | 659 |
|
|
2015
Q2 | $2.18M | Buy |
+19,059
| New | +$2.18M | 0.01% | 694 |
|